E701125e Efea 470b Ac59 D9db068436a6 01
Pyridostigmine Bromide Tablet
Product Images NDC 68382-659
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pyridostigmine Bromide (NDC 68382-659). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
E701125e Efea 470b Ac59 D9db068436a6 02
Each tablet of this drug contains 60 mg of pyridostigmine bromide, USP. The tablets are hygroscopic and hence extremely moisture sensitive. The usual dosage is mentioned in the package insert. The drug should be kept in its original container and stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Caution must be exercised to keep out of reach of children, and the desiccant must not be removed. The drug is manufactured by Cadila Healthcare Ltd. in India and distributed by Zydus Pharmaceuticals (USA) Inc. The over-coding template shows important information like the GTIN, SN, EXP and LOT. There are some instructions too regarding printing and varnishing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
